Ami Fadia
Stock Analyst at Needham
(3.31)
# 991
Out of 4,876 analysts
427
Total ratings
43.35%
Success rate
3.37%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $30 | $21.74 | +37.99% | 10 | Jun 26, 2025 | |
| RVMD Revolution Medicines | Reiterates: Buy | $57 | $36.89 | +54.51% | 24 | Jun 24, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $9 | $3.34 | +169.46% | 17 | Jun 18, 2025 | |
| COGT Cogent Biosciences | Reiterates: Hold | n/a | $7.28 | - | 23 | Jun 17, 2025 | |
| SAGE Sage Therapeutics | Reiterates: Hold | n/a | $9.10 | - | 22 | Jun 16, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $80 | $42.59 | +87.84% | 12 | Jun 12, 2025 | |
| BIIB Biogen | Reiterates: Hold | n/a | $125.01 | - | 41 | Jun 12, 2025 | |
| JAZZ Jazz Pharmaceuticals | Reiterates: Buy | $202 | $106.10 | +90.39% | 32 | Jun 11, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $153 → $150 | $104.17 | +44.00% | 15 | Jun 9, 2025 | |
| BPMC Blueprint Medicines | Downgrades: Hold | $130 | $128.14 | +1.45% | 31 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $13.09 | +167.38% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $28.61 | +57.29% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $88 | $52.76 | +66.79% | 29 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.75 | +567.02% | 9 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.79 | +116.28% | 36 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $27 | $6.50 | +315.38% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $31.66 | +54.77% | 37 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $139 | $125.97 | +10.34% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $7.03 | +312.52% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $16.27 | +1,866.81% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $23.90 | +213.81% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.99 | +2,169.29% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $26.73 | +135.69% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $12 → $5 | $3.86 | +29.53% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $16.70 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $2.10 | +947.62% | 4 | Jan 3, 2018 |
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $30
Current: $21.74
Upside: +37.99%
Revolution Medicines
Jun 24, 2025
Reiterates: Buy
Price Target: $57
Current: $36.89
Upside: +54.51%
Immuneering
Jun 18, 2025
Reiterates: Buy
Price Target: $9
Current: $3.34
Upside: +169.46%
Cogent Biosciences
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.28
Upside: -
Sage Therapeutics
Jun 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.10
Upside: -
Praxis Precision Medicines
Jun 12, 2025
Reiterates: Buy
Price Target: $80
Current: $42.59
Upside: +87.84%
Biogen
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $125.01
Upside: -
Jazz Pharmaceuticals
Jun 11, 2025
Reiterates: Buy
Price Target: $202
Current: $106.10
Upside: +90.39%
Axsome Therapeutics
Jun 9, 2025
Maintains: Buy
Price Target: $153 → $150
Current: $104.17
Upside: +44.00%
Blueprint Medicines
Jun 2, 2025
Downgrades: Hold
Price Target: $130
Current: $128.14
Upside: +1.45%
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $13.09
Upside: +167.38%
May 28, 2025
Initiates: Buy
Price Target: $45
Current: $28.61
Upside: +57.29%
May 23, 2025
Maintains: Buy
Price Target: $75 → $88
Current: $52.76
Upside: +66.79%
May 13, 2025
Reiterates: Buy
Price Target: $5
Current: $0.75
Upside: +567.02%
May 8, 2025
Reiterates: Buy
Price Target: $19
Current: $8.79
Upside: +116.28%
May 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $6.50
Upside: +315.38%
May 7, 2025
Reiterates: Buy
Price Target: $49
Current: $31.66
Upside: +54.77%
May 6, 2025
Maintains: Buy
Price Target: $138 → $139
Current: $125.97
Upside: +10.34%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $7.03
Upside: +312.52%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $16.27
Upside: +1,866.81%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $23.90
Upside: +213.81%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.99
Upside: +2,169.29%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $26.73
Upside: +135.69%
Jan 30, 2019
Downgrades: Market Perform
Price Target: $12 → $5
Current: $3.86
Upside: +29.53%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $16.70
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $2.10
Upside: +947.62%